Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
Crane Company	CR	5. nov 2024	168.99	+5.53
Crane NXT	CXT	5. nov 2024	54.00	+1.22
Crawford & Company A	CRD-A	5. nov 2024	11.58	+0.17
Crawford & Company B	CRD-B	5. nov 2024	11.56	+1.94
Creative Media & Community Trust	CMCT	5. nov 2024	0.37	-3.26
Creative Medical Technology	CELZ	5. nov 2024	3.15	-10.26
Creative Realities	CREX	5. nov 2024	4.08	+2.77
Credicorp	BAP	5. nov 2024	181.79	+0.15
Credit Acceptance	CACC	5. nov 2024	433.00	+2.21
Credit Enhanced Corts Trust Aon Capital A	KTN	5. nov 2024	27.06	+0.07
Credit Suisse Ag	SLVO	5. nov 2024	82.55	+0.30
Credit Suisse Ag	GLDI	5. nov 2024	158.34	-0.19
Credit Suisse Asset Management Income Fund	CIK	5. nov 2024	2.96	+0.51
Credit Suisse Gold Shares Covered Calls ETN	USOI	5. nov 2024	66.64	+0.83
Credit Suisse High Yield Bond Fund	DHY	5. nov 2024	2.16	+0.93
Credo Technology	CRDO	5. nov 2024	41.85	+4.44
Crescent Capital BDC	CCAP	5. nov 2024	17.66	+0.63
Crescent Energy	CRGY	5. nov 2024	12.95	+3.35
Cresud A ADR	CRESY	5. nov 2024	9.65	+5.58
Crexendo	CXDO	5. nov 2024	5.82	+1.57
CRH	CRH	5. nov 2024	96.91	+2.60
Cricut A	CRCT	5. nov 2024	6.57	+3.14
Crinetics Pharmaceuticals	CRNX	5. nov 2024	57.81	+1.74
CRISPR Therapeutics	CRSP	5. nov 2024	50.36	-0.45
Criteo ADR	CRTO	5. nov 2024	34.86	+1.34
Critical Metals	CRML	5. nov 2024	6.46	+3.36
Crocs	CROX	5. nov 2024	105.22	-1.01
Cronos Group	CRON	5. nov 2024	2.22	+0.91
Cross Country Healthcare	CCRN	5. nov 2024	11.45	+2.05
Cross Timbers Royalty Royalty Trust	CRT	5. nov 2024	9.88	-1.84

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.